Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Lenka Kellermann"'
Autor:
Karthik Ramasamy, K Martin Kortum, Evi Zhuleku, Elena Zamagni, Tim D’estrube, Soham Shukla, Moritz Lehne, Marco Ghiani, Maya Hanna, Ulf Maywald, Thomas Wilke, Lenka Kellermann, Sue Perera
Publikováno v:
HemaSphere, Vol 7, p e6013857 (2023)
Externí odkaz:
https://doaj.org/article/4df529938ccb4e3f8672e2d14695487b
Autor:
Kirsten Merx, Manuel Barreto Miranda, Lenka Kellermann, Ulrich Mahlknecht, Oliver Lange, Michael Gonnermann, Ralf-Dieter Hofheinz
Publikováno v:
Gastroenterology Research and Practice, Vol 2016 (2016)
We analysed trends over time in palliative first-line chemotherapy in patients with locally advanced or metastatic esophagogastric cancer. Special focus was on frequency and quality of HER2-testing and trends in drug use in combination with trastuzum
Externí odkaz:
https://doaj.org/article/42b020bea69746eab21d828f342d9795
Autor:
Maximilian Merz, Lenka Kellermann, Muhammad Akram, Jordan M. Schecter, Nolen J. Perualila, Tonia Nesheiwat, Francesca Ghilotti, Mounzer Agha, Parameswaran Hari, Hartmut Goldschmidt, Carolyn C. Jackson, Joris Diels, Yunsi Olyslager, Jedelyn Cabrieto, Henrik Sliwka, Benjamin Haefliger, Sundar Jagannath
Publikováno v:
Cancers
Cancers; Volume 13; Issue 23; Pages: 5996
Cancers, Vol 13, Iss 5996, p 5996 (2021)
Cancers; Volume 13; Issue 23; Pages: 5996
Cancers, Vol 13, Iss 5996, p 5996 (2021)
Simple Summary There is an urgent need to develop new treatments for patients with relapsed/refractory multiple myeloma (RRMM) to address unmet medical needs. Chimeric antigen receptor T-cell (CAR-T) therapy is a novel approach with the potential for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::034a4286d31d251d483fd65adc4d5a13
https://ul.qucosa.de/id/qucosa:85089
https://ul.qucosa.de/id/qucosa:85089
Autor:
Emmanouil Nikolousis, Hartmut Goldschmidt, Brigitte Kolb, Manuel Delgado Pérez, Athanasios Zomas, Francisco Javier Expósito González, Isabelle Vande Broek, Maximilian Merz, Lenka Kellermann, Argiris Symeonidis
Publikováno v:
Blood. 134:3115-3115
Background Recently, treatment options for RRMM have increased substantially with multiple approvals of novel agents/combination, making the treatment algorithm increasingly complex, with changes driven chiefly by access to novel agents/regimens. Fur
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f1fac6ed0b9ccabdf4298ec16aed4b90
https://doi.org/10.1182/blood-2019-122706
https://doi.org/10.1182/blood-2019-122706
Autor:
Martina Schoehl, Vishal Patel, Hartmut Goldschmidt, Andrea Lebioda, Lucie Kutikova, Lenka Kellermann, Maximilian Merz
Publikováno v:
Blood. 134:4734-4734
Background: The RRMM treatment landscape has increased in complexity in recent years due to the availability of novel agents. In this study, we evaluated treatment patterns over 3 years in real-world RRMM pts treated with regimens containing one or m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::edf244eb8be4dcd77d379740ac9eb49b
https://doi.org/10.1182/blood-2019-128030
https://doi.org/10.1182/blood-2019-128030
Autor:
Wolfgang Knauf, Maximilian Merz, Wolfram Poenisch, Lenka Kellermann, Joern Kohnke, Hartmut Goldschmidt, Hans-Joachim Tischler
Publikováno v:
Annals of hematology. 96(6)
A nationwide, multi-institutional survey was performed in 2011 and 2015 to analyze routine practice for myeloma patients outside clinical trials in Germany. We contacted university hospitals, community hospitals, and office-based hematologists in ord
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ae9ac67573fc84af5b489dc1d6402d8
https://pubmed.ncbi.nlm.nih.gov/28409228
https://pubmed.ncbi.nlm.nih.gov/28409228
Autor:
Ralf-Dieter Hofheinz, Lenka Kellermann, Kirsten Merx, Oliver Lange, Manuel Barreto Miranda, Ulrich Mahlknecht, Michael Gonnermann
Publikováno v:
Gastroenterology Research and Practice
Gastroenterology Research and Practice, Vol 2016 (2016)
Gastroenterology Research and Practice, Vol 2016 (2016)
We analysed trends over time in palliative first-line chemotherapy in patients with locally advanced or metastatic esophagogastric cancer. Special focus was on frequency and quality of HER2-testing and trends in drug use in combination with trastuzum
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9eb6e9341140aef50f5e806b12ccbc2f
Autor:
Andrea Kündgen, B. Paessens, Norbert Gattermann, Ulrich Germing, Lenka Kellermann, Matti Zeffel
Publikováno v:
Onkologie. 35:350-356
Myelodysplastic syndromes (MDS) are a heterogenous group of clonal hematopoietic stem cell disorders.In order to assess current diagnosis and treatment patterns in Germany, the data of 269 patients with MDS from 57 representative centers were analyze
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::38e6c90f6862ea24022d7074f3b31453
https://doi.org/10.1159/000338939
https://doi.org/10.1159/000338939
Autor:
Barbara Eichhorst, Lenka Kellermann, Alexander Mensch, Dirk Müller, Daniele Civello, Michael Hallek, Peter Kaiser, Kirsten Fischer, Günter Fingerle-Rowson, Stephanie Stock, Ronald Walshe, Jasmin Bahlo, Lisa Borsi, M. Reiser
Publikováno v:
Leukemialymphoma. 57(5)
The cost-effectiveness of rituximab in combination with fludarabine/cyclophosphamide (R-FC) for the first line treatment of chronic lymphocytic leukemia (CLL) was evaluated. Based on long-term clinical data (follow-up of 5.9 years) from the CLL8-tria
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f5c067d716f11fcd746dc64bf3fd6662
https://pubmed.ncbi.nlm.nih.gov/26584689
https://pubmed.ncbi.nlm.nih.gov/26584689
Autor:
Martin Dreyling, Thomas Höhler, Lenka Kellermann, Stefan Fries, Anna-Katharina Zoellner, P. Kiewe, Angelika Böhme
Publikováno v:
Annals of hematology. 95(6)
Chronic lymphocytic leukemia (CLL) is the most common subtype of adult leukemia in the western world. We here report a nationwide survey monitoring the treatment decisions concerning CLL patients in Germany in 2011 and compare treatment trends to seq
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d22e6a54ae4dd925cc10e02e50caac1
https://pubmed.ncbi.nlm.nih.gov/27021305
https://pubmed.ncbi.nlm.nih.gov/27021305